Renaissance Technologies - BRAINSTORM CELL THERAPEUTICS ownership

BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 40 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of BRAINSTORM CELL THERAPEUTICS
ValueSharesWeighting
Q3 2023$41
-90.4%
203,600
-1.5%
0.00%
-100.0%
Q2 2023$426
+2142.1%
206,800
+1652.5%
0.00%
Q4 2022$19
-100.0%
11,800
-78.8%
0.00%
Q3 2022$246,000
+423.4%
55,700
+225.7%
0.00%
Q2 2022$47,000
-74.0%
17,100
-64.1%
0.00%
Q2 2021$181,000
+46.0%
47,600
+73.7%
0.00%
Q4 2020$124,000
-92.2%
27,400
-80.6%
0.00%
-100.0%
Q2 2020$1,583,000
-40.8%
141,238
-75.5%
0.00%
-66.7%
Q1 2020$2,676,000
+87.3%
576,638
+72.7%
0.00%
+200.0%
Q4 2019$1,429,000
+23.3%
333,932
+12.4%
0.00%0.0%
Q3 2019$1,159,000
+30.8%
297,138
+32.4%
0.00%0.0%
Q2 2019$886,000
+0.7%
224,377
+10.7%
0.00%0.0%
Q1 2019$880,000
+35.8%
202,657
+11.1%
0.00%0.0%
Q4 2018$648,000
+26.8%
182,457
+36.3%
0.00%0.0%
Q3 2018$511,000
-30.1%
133,900
-34.5%
0.00%
Q2 2018$731,000
+160.1%
204,501
+129.5%
0.00%
Q1 2018$281,000
-37.4%
89,101
-22.2%
0.00%
Q4 2017$449,000
+372.6%
114,550
+396.9%
0.00%
Q3 2017$95,00023,0550.00%
Other shareholders
BRAINSTORM CELL THERAPEUTICS shareholders Q2 2018
NameSharesValueWeighting ↓
Weaver Consulting Group 130,000$437,0000.21%
Ikarian Capital, LLC 304,161$1,022,0000.13%
ABNER HERRMAN & BROCK LLC 265,000$890,0000.12%
S.C. Financial Services, Inc. 15,285$51,0000.06%
JMAC ENTERPRISES LLC 45,430$153,0000.04%
CFO4Life Group, LLC 12,000$40,0000.01%
OSAIC HOLDINGS, INC. 10,839$1,329,0000.00%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 3,000$10,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 29,186$98,0000.00%
RAYMOND JAMES & ASSOCIATES 190,403$640,0000.00%
View complete list of BRAINSTORM CELL THERAPEUTICS shareholders